← Back to Clinical Trials
Recruiting NCT05325034
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
Trial Parameters
Condition Cardiovascular Diseases
Sponsor Stephen Nicholls
Study Type INTERVENTIONAL
Phase N/A
Enrollment 2,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2022-09-15
Completion 2026-12
Interventions
Early Intervention
Brief Summary
Multinational, patient-level randomised, multi-phase standard-of-care control arm, parallel group, implementation study. Patients will be recruited during hospitalisation and be randomised to a multifaceted intervention to be delivered either 'early' (baseline) or 'late' (6 months), in a 1:1 fashion.
Eligibility Criteria
Inclusion Criteria: * 18 years of age * Admission for Type I myocardial infarction Exclusion Criteria: * LDL \<1.4mmol/L at baseline * Unable to provide contact details of primary care physician/general practitioner * Unable to provide written informed consent. * Unlikely to survive \>12 months
Related Trials
NCT05943821
The Effect of Allopurinol on the Risk of Cardiovascular Events in Patients with Cardiovascular Risk
View Trial →
NCT04055428
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
View Trial →
NCT06826872
Efficacy and Safety of SPC1001 in Patients With Essential Hypertension
View Trial →